Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

  Name of person dealing (Note 1)

Barclays PLC.

  Company dealt in

WILLIS TOWERS WATSON PLC

  Class of relevant security to which the 

ORD

  dealings being disclosed relate (Note 2)
  Date of dealing

30 June 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD    
 

Long

Short

 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

1,393,183

1.08%

454,224

0.35%

   

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

333,000

0.26%

383,659

0.30%

   

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

1,726,183

1.34%

837,883

0.65%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

12

195.3233   USD

Purchase

15

195.9600   USD

Purchase

15

195.9200   USD

Purchase

77

191.6000   USD

Purchase

100

197.6050   USD

Purchase

100

196.9300   USD

Purchase

200

194.2598   USD

Purchase

200

194.8800   USD

Purchase

201

195.5926   USD

Purchase

300

194.2333   USD

Purchase

353

196.9163   USD

Purchase

380

195.7846   USD

Purchase

1,130

196.6954   USD

Purchase

1,168

196.8935   USD

Purchase

3,787

196.3492   USD

Purchase

5,434

194.4886   USD

Purchase

5,930

195.6760   USD

Purchase

9,162

196.9500   USD

Purchase

13,124

195.8133   USD

Purchase

96,770

196.0567   USD

Sale

1

191.3000   USD

Sale

3

195.2433   USD

Sale

4

196.7900   USD

Sale

8

196.7700   USD

Sale

8

196.6050   USD

Sale

8

196.1700   USD

Sale

8

196.5300   USD

Sale

9

195.3500   USD

Sale

10

195.0400   USD

Sale

12

196.5200   USD

Sale

14

196.8771   USD

Sale

28

196.6714   USD

Sale

30

195.9200   USD

Sale

36

196.5088   USD

Sale

39

196.7130   USD

Sale

61

195.6900   USD

Sale

100

193.4300   USD

Sale

100

194.9800   USD

Sale

100

195.5000   USD

Sale

100

195.6550   USD

Sale

100

196.2800   USD

Sale

100

196.9507   USD

Sale

130

193.8165   USD

Sale

175

195.9614   USD

Sale

200

194.8800   USD

Sale

200

196.5800   USD

Sale

239

196.4956   USD

Sale

260

195.3596   USD

Sale

330

194.2034   USD

Sale

362

196.3113   USD

Sale

1,100

196.7715   USD

Sale

1,168

196.8935   USD

Sale

1,453

195.9615   USD

Sale

2,233

195.1793   USD

Sale

2,324

196.5774   USD

Sale

2,600

195.8032   USD

Sale

2,730

196.0192   USD

Sale

3,300

195.6333   USD

Sale

3,448

196.1871   USD

Sale

3,702

194.1855   USD

Sale

3,710

196.0214   USD

Sale

4,300

195.5458   USD

Sale

5,653

196.1432   USD

Sale

5,872

196.1926   USD

Sale

6,703

196.0493   USD

Sale

8,032

196.2865   USD

Sale

10,432

196.9500   USD

Sale

10,818

196.2987   USD

Sale

13,411

195.8225   USD

Sale

43,591

195.9764   USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

2 Jul 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected  
If a connected EFM, state nature of connection  

 

Short Name: BARCLAYS PLC
Category Code: RET
Sequence Number: 703186
Time of Receipt (offset from UTC): 20200702T123038+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC